AstraZeneca’s Imfinzi gets Breakthrough Therapy Designation from FDA
31 July 2017
AstraZeneca and Merck in $8.5-billion oncology deal
27 July 2017
AstraZeneca licenses cancer drug Zoladex to TerSera Therapeutics
21 February 2017
AstraZeneca to cut 700 positions
09 December 2016
AstraZeneca inks $1bn plus drug development deal with Bicycle Therapeutics
02 December 2016
Pfizer to acquire part of AstraZeneca's antibiotics business
24 August 2016
AstraZeneca's bid to save Crestor sales fails, court turns down IPR protection request till 2026
21 July 2016
FluMist failed to protect kids and adults against flu
23 June 2016
Aspen Pharmacare to buy AstraZeneca’s anaesthetics portfolio for at least $520 mn
09 June 2016
AstraZeneca drug awarded orphan status in thyroid cancer
13 May 2016
AstraZeneca, Reckitt Benckiser face investor ire over fat executive pay
02 May 2016
AstraZeneca to sell US rights for its gout drug to Ironwood Pharmaceuticals
26 April 2016
AstraZeneca project to sequence 2 mn genomes for new medicines
23 April 2016
AstraZeneca licenses hypertension drug to China Medical System for $310 million
01 March 2016
AstraZeneca to sell rights to two heart drugs to China Medical for $500 mn
01 March 2016
EU clears AstraZeneca’s new 'Brilique’ dosage for extended treatment of heart patients
19 February 2016
UK drugmaker AstraZeneca agrees to acquire majority stake in Acerta Pharma
18 December 2015
AstraZeneca boost oncology portfolio with $4bn Acerta Pharma deal
17 December 2015
AstraZeneca to acquire Takeda’s respiratory business for $575 million
16 December 2015
AstraZeneca to sell the US rights of Crohn disease drug Entocort to Perrigo
24 November 2015
AstraZeneca to buy ZS Pharma for $2.7 bn
06 November 2015
US FDA approves AstraZeneca’s new dosage for heart drug 'Brilinta'
04 September 2015
Valeant to buy rights to AstraZeneca's psoriasis drug
01 September 2015
Sanofi to buy AstraZeneca's cancer drug for upto $300 mn
27 July 2015
AstraZeneca to sell gastrointestinal drug Entocort to Tillotts Pharma
09 July 2015
AstraZeneca,Juno partner to study immune therapy drugs
24 April 2015
New pill by AstraZeneca shown to delay lung cancer progression by more than a year
20 April 2015
New AIIMS, hike in health policy premiums welcome
28 February 2015
AstraZeneca acquires Actavis’s respiratory business for $600 million
06 February 2015
AstraZeneca strikes three oncology deals
04 November 2014
Pfizer's $11-bn share repurchase ends chances of renewed bid for AstraZeneca
25 October 2014
US government clears AstraZeneca’s Brilinta over concerns related to trial process
20 August 2014
AstraZeneca to acquire rights to Almirall’s lung drugs
30 July 2014
AstraZeneca, Roche, Qiagen in collaboration on lung cancer tests
28 July 2014
AstraZeneca plans £330m R&D centre and corporate HQ in Cambridge
18 July 2014
AstraZeneca India delisting under Sebi lens for cheating investors
25 June 2014
US FDA gives `fast-track’ status for AstraZeneca’s novel antibiotic for treatment of gonorrhea
04 June 2014
Pfizer drops AstarZeneca take over bid
28 May 2014
AstraZeneca rejects Pfizer’s third takeover offer
19 May 2014
Pfizer raises bid for AstraZeneca to $118.8 bn, says latest offer is final
19 May 2014
AstraZeneca plans research alliance with MRC Laboratory of Molecular Biology
16 May 2014
AstraZeneca snubs Pfizer’s “opportunistic” bid
13 May 2014
US, British lawmakers wary of Pfizer’s bid to buy AstraZeneca
10 May 2014
Amgen, AstraZeneca announce success of psoriasis drug trial
10 May 2014
Pfizer seeks to allay fears over AstraZeneca deal
07 May 2014
Pfizer considering "all strategies" in AstraZeneca bid
06 May 2014
Cable admits Pfizer-AstaraZeneca deal involves ‘national interest’ issues
05 May 2014
AstraZeneca rejects Pfizer’s revised $106 billion offer
02 May 2014
AstraZeneca to consider Pfizer’s $106-bn bid
02 May 2014
Pfizer confirms AstraZeneca's rejection; to explore options
28 April 2014
AstraZeneca’s Q1-14 revenue marginally up at$6.42 bn, profit falls
24 April 2014
Pfizer weighs $101-bn bid for AstraZeneca
21 April 2014
AstraZeneca in strategic R&D collaboration with UK Medical Research Council
01 April 2014
AstraZeneca completes buy-out of Sumitomo Chemical’s stake in AstraZeneca KK
26 March 2014
AstraZeneca confirms de-listing from Indian bourses
19 March 2014
AstraZeneca to acquire Bristol-Myers Squibb’s stake in diabetes business
20 December 2013
S Korean companies Hanmi and Amneal Pharm launch first copy of AstraZeneca's Nexium in US
20 December 2013
AstraZeneca to buy biotech company Spirogen in $440 mn deal
15 October 2013
AstraZeneca to acquire respiratory drug company Pearl Therapeutics in $1.15 bn deal
10 June 2013
AstraZeneca's withdrawal of drug from regulatory tests hits partner Rigel's shares
05 June 2013
AstraZeneca site to emerge as biotech hub
08 May 2013
AstraZeneca in $200-mn cancer drug development deal with Bind Therapeutics
22 April 2013
AstraZeneca’s rheumatoid arthritis pill fostamatinib shows mixed results in trial
08 April 2013
AstraZeneca settles Crestor lawsuit with Egis and Actavis
25 March 2013
AstraZeneca to eliminate 1,600 jobs in major R&D restructuring
19 March 2013
AstraZeneca chief hints at changes with adverse outlook as patents expire
02 February 2013
AstraZeneca loses appeal on lung cancer drug rights in India
28 November 2012
AstraZeneca to pay Bristol-Myers Squibb $135 mn more for Amylin drug rights
10 August 2012
Bristol-Myers Squibb, AstraZeneca expand alliance through Amylin acquisition
30 June 2012
AstraZeneca Q1 profit slumps; CEO quits
27 April 2012
AstraZeneca eliminates 7,300 jobs in major restructuring
03 February 2012
AstraZeneca to buy China’s generic maker Guangdong BeiKang Pharma
08 December 2011
AstraZeneca to cut 1,150 sales jobs in the US
08 December 2011
AstraZeneca - Bristol-Myers to present new data on diabetes drug
27 October 2011
AstraZeneca close to selling dental implants unit to Dentsply for $1.8 billion: report
21 June 2011
Russia, China precede India for AstraZeneca's expansion plans
18 June 2011
AstraZeneca to pay $250,000 to 124 women for sex discrimination
07 June 2011
AstraZeneca, Daiichi Sankyo to promote Amgen's new bone cancer drug
24 May 2011
AstraZeneca saves over $1 billion in tax dispute settlement
28 March 2011
AstraZeneca to pay $198 million to settle 17,500 Seroquel lawsuits
09 August 2010
AstraZeneca scrip slumps after buy-back offer
07 July 2010
AstraZeneca settles US drug pricing suit for $103 million
19 June 2010
AstraZeneca settles Seroquel case with US government for $520 million
28 April 2010
AstraZeneca, Bristol-Myers Squibb in diabetes research alliance
01 April 2010
Torrent in AstraZeneca's debut deal to sell branded generics
11 March 2010
AstraZeneca settles UK tax dispute with £505 million payout
24 February 2010
AstraZeneca India to pay 500 per cent dividend
23 February 2010
AstraZeneca inks arthritis drug deal with Rigel
16 February 2010
US FDA approves AstraZeneca's Crestor
09 February 2010
AstraZeneca reports profit, cuts 8,000 jobs to cut costs
29 January 2010
AstraZeneca settles another Nexium patent litigation for US sales
07 January 2010
AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs
24 December 2009
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
AstraZeneca, Merck & Co to in phase 1 cancer drug research
01 June 2009
Jubilant signs research deal with Anglo-Swedish firm AstraZeneca
06 May 2009
Infosys wins multi-million dollar AstraZeneca deal
15 December 2008
AstraZeneca, Abraxis rethink cancer drug deal
26 November 2008
AstraZeneca agrees to cut drug prices in UK, stock plummets
20 November 2008
Fish oil better than AstraZeneca's Crestor says new heart-failure study
01 September 2008
US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel
03 July 2008
Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US
15 April 2008
AstraZeneca forms clinical research venture with private equity firms
18 February 2008
AstraZeneca acquires paediatric asthma development programmes from Verus Pharmaceuticals
25 September 2007
AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion
28 April 2007
Global collaboration to develop new anti-obesity compounds
02 February 2007
Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement
24 November 2005
AstraZeneca sues Ranbaxy on Nexium patent
22 November 2005
AstraZeneca to drop Viozan
29 June 2001
AstraZeneca launches $ 100 million facility in China
30 April 2001
AstraZeneca to acquire development rights from Cyclacel
17 April 2001
AstraZeneca sells off speciality chemicals
13 May 1999
Cheminor unfazed by AstraZeneca patent infringement suit
13 May 1999
 search domain-b